Interleukin-10 compositions for the treatment of adenocarcinomas
US7939056B2 · kind B2 · utility
25Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2006 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Apr 28, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/2066
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods for the treatment of adenocarcinomas that are characterized by the overexpression of a particular oncogene, Pim-1. The procedure involves administering a therapeutically effective amount of interleukin-10 that has been coupled to a carrier that increases its circulating plasma half-life.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.